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INTRODUCTION
Nitric oxide (NO) is an important bioregulatory mediator
involved in a variety of processes in cardiovascular, nervous,
and immune systems (1). It is derived from the amino acid
L-arginine in a reaction catalyzed by three different isoforms
of nitric oxide synthases (NOS). The constitutive calcium-
dependent isoforms, which are known to generate NO at low
concentrations, are found in endothelial cells (eNOS) and
neuronal tissue (nNOS) (2). An inducible, calcium-indepen-
dent isoform (iNOS) is expressed in macrophages, neutrophils,
endothelial cells, hepatocytes, cardiac myocytes, chondrocytes,
and many other cell types (3). It is induced by cytokines and
can generate locally high concentrations of NO for prolonged
periods of time (4). NO metabolites can mediate genotoxic-
ity and influence multistage carcinogenesis by causing DNA
damage through nitrosative deamination, DNA strand break-
age, or DNA modification (5, 6). 
Several human gastrointestinal neoplasms express iNOS
including gastric cancer, colonic adenomas, Barrett’s esoph-
agus and associated adenocarcinomas, hepatocellular carci-
noma and cholangiocarcinoma (7-10). In addition, iNOS
expression was observed in the epithelial cells of rodent colon
tumors and stromal cells beneath Barrett’s metaplastic epithe-
lium surgically induced by chronic duodenal reflux in rat
(11, 12). Reflux of duodenal contents in addition to gastric
acid in human seems to contribute to the development of
esophagitis and Barrett’s esophagus (13, 14). Experimental
studies in rat have shown that chronic contact of duodenal
contents per se caused squamous cell carcinoma, adenosqua-
mous carcinoma and adenocarcinoma in esophagus (15-17).
However, the precise mechanism by which duodenal reflux
causes esophageal injury and predisposes to neoplasia is uncer-
tain. We have reported that prostaglandin biosynthetic path-
way has an important role in rat esophageal squamous dys-
plasia and glandular metaplasia induced by chronic duodenal
contents reflux (18). Several studies have suggested a cross
link between the iNOS and cyclooxygenase pathway (19).
Consequently, to study iNOS expression may be useful in
understanding the pathogenesis of esophageal lesions related
to chronic duodenal contents reflux. In this study, we investi-
gated the immunolocalization and expression of iNOS in Bar-
rett’s esophagus induced by esophagoduodenal anastomosis.
MATERIALS AND METHODS
Animals
Thirty seven 7-week old male Sprague-Dawley rats (KIST,
Daejun, Korea) were used for control (n=8) and experimen-
tal group (n=29). Throughout the experiment, all rats were
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Expression of Inducible Nitric Oxide Synthase Is Increased in Rat
Barrett's Esophagus Induced by Duodenal Contents Reflux
Barrett’s esophagus is a premalignant condition of esophageal adenocarcinoma.
Inducible nitric oxide synthase (iNOS) is induced by cytokines and can generate
locally high concentrations of nitric oxide (NO), whose metabolites can mediate
genotoxicity and influence multistage carcinogenesis by causing DNA damage.
Therefore, we evaluated the immunolocalization and expression of iNOS in surgi-
cally induced rat Barrett’s esophagus. Esophagoduodenal anastomosis was per-
formed in rats for inducing reflux of duodenal contents. Rats were killed at postop-
erative 10, 20, 30 and 40 weeks. We examined histologic changes and iNOS
expression in esophagus by immunohistochemistry and reverse transcription-poly-
merase chain reaction. Eighty six percent of experimental rats showed Barrett’s
esophagus above esophagoduodenal junction. iNOS immunoreactivity was clear-
ly observed in the epithelial cells of Barrett’s esophagus, predominantly at the api-
cal surface of epithelial cells. Cytoplasmic staining was also seen only in atypical
Barrett’s esophagus. iNOS mRNA was detected only in the lower esophagus of
experimental group. In conclusion, this study suggests that iNOS has some roles
on Barrett’s esophagus formation.
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housed in a controlled environment with 12 hr light/dark
cycle and temperature of 22±2℃. After an acclimatization
period of 1 week, 29 experimental rats were randomly divid-
ed into four groups in a time-course design and underwent
an esophagoduodenostomy for inducing duodenal contents
reflux for 10 (n=2), 20 (n=12), 30 (n=8) and 40 (n=7) weeks,
respectively. Eight control rats underwent sham operation. At
the end of the appropriate time period for each group, the
control and experimental rats were killed with ether.
Surgical technique and preparation of tissue samples
Solid food was withdrawn for 24 hr and water for 12 hr
before surgery. Anesthesia was induced and maintained with
isoflurane-air mixture. According to the Clark model, eso-
phagoduodenal anastomosis was performed (Fig. 1) (20). In
short, a midline laparotomy was performed, and the gastro-
esophageal junction was identified and mobilized while care-
fully preserving the vagus nerve. The gastroesophageal junc-
tion was ligated, and the distal esophagus was transected 2
mm above the ligature. A total of eight polypropylene 7-0
sutures were placed. Five mm transverse enterostomy was
created on the antimesenteric border of duodenum 1 cm dis-
tal to pylorus. An end-to-side esophagoduodenstomy was per-
formed. To compensate for blood loss, 1 mL of sterile 0.9%
normal saline was instilled in the peritoneal cavity. The abdo-
minal incision was closed in 2 layers and postoperatively the
rats were allowed to drink water after 6 hr and were fed on
the following day. Immediately after death, the entire esopha-
gus, contiguous anastomotic site and 0.7 cm of duodenal
mucosa were removed and the lumen was longitudinally
opened (Fig. 2). After snap freezing, a representative sample
of duodenum, and upper and lower esophagus was stored at
-70℃ for reverse transcription-polymerase chain reaction
(RT-PCR). The remaining esophagus including anastomotic
site and 0.7 cm of duodenal mucosa was fixed in 10% neu-
tral buffered formalin for 24 hr for histological study and
immunohistochemistry.
Pathological analysis
For histologic evaluation, formalin-fixed tissues were em-
bedded in paraffin, cut at 4  m and stained with H&E. Two
pathologists blinded to the experimental groups have assessed
all tissues independently. Diagnosis of Barrett’s esophagus was
made by the presence of columnar metaplasia containing in-
testinal type goblet cells surrounded by squamous epithelium
above the anastomotic site. In addition, Barrett’s esophagus was
divided into short and long one according to distance from
anastomotic site; it was regarded as long one when the special-
ized intestinal type epithelium was present at a length of >0.5
cm above the anastomotic site. Atypical Barrett’s esophagus
was diagnosed when glands with atypical features were pre-
sent both at the superficial and deep portions of the wall. 
Immunohistochemistry
Serial sections of 4  m thickness were made and spread on
poly-L-lysine coated slides. Paraffin sections were immersed
in three changes of xylene and hydrated using a graded series
of alcohol. Antigen retrieval was performed routinely by im-
mersing the sections in 0.01 M citrate buffer (pH 6.0) in a
pressure cooker by autoclaving for 15 min. Endogenous per-
oxidase activity was blocked with 3% hydrogen peroxide for
15 min and then incubated with a primary antibody over-
night in a humidified chamber at 4℃. Primary antibodies
were polyclonal rabbit anti-iNOS (Transduction laboratories,
Fig. 1. End to side esophagoduodenal anastomosis.
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Fig. 2. Gross finding of esophagoduodenal anastomosis group.
Experimental rats show abnormally dilated esophagus, and eso-
phageal inner surface displays whitish nodular patches, which
are prominent in lower esophagus. Superficial ulcers are present
mainly in lower esophagus. E, esophagus; E-D, anastomosis of
esophagoduodenostomy site; S, stomach; D, duodenum.
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Lexington, KY, U.S.A.) at a dilution of 1:300. Staining was
achieved with a DAKO LSAB+kit (DAKO, Santa Barbara,
CA, U.S.A.) and developed with diaminobenzidine tetrahy-
drochloride. Sections were counterstained for 5 min with
Meyer’s hematoxylin and then mounted. The hepatic tissue
of rat in which lipopolysaccharide (Sigma Chemical Co., St.
Louis, MO, U.S.A.) was intraperitoneally administered was
used as a positive control. As a negative control, rabbit IgG
(DAKO) was used instead of primary antibodies. An estima-
tion of immunohistochemical expression of iNOS was eval-
uated according to both intensity and area of signal: 0, absent;
1, mild: 2, moderate; 3, severe. 
RNA extraction and RT-PCR analysis
Total RNA was extracted and purified from frozen tissues
using GeneElute Mammalian Total RNA kit (Sigma Chemi-
cal Co.) acccording to manufacturer’s instructions. The RNA
was quantified by determining absorbance at 260 nm. Two  g
of total RNA from each sample was reverse transcribed into
cDNA using Superscript II reverse transcriptase (Life Tech-
nologies, Inc., Rockville, MD, U.S.A.) and random hexamer
primers (Takara, Shiga, Japan). The PCR primers were as fol-
lows: glyceraldehydes 3-phosphate dehydrogenase (GAPDH)
(311 bp), sense 5 -GAA CGG GAA GCT CAC TGG CAT
GGC-3 , antisense 5 -TGA GGT CCA CCA CCC TGT TGC
TG-3 ; iNOS (397 bp), sense 5 -CCA CAA TAG TAC AAT
ACT ACT TGG-3 , antisense 5 -ACG AGG TGT TCA GCG
TGC TCC ACG-3 . After denaturation at 95℃ for 5 min,
cDNA amplification was carried out by running 32 cycles
of denaturation at 94℃ for 1 min, annealing at 58℃ for
45 sec and extension at 72℃ for 45 sec, followed by further
incubation at 72℃ for 7 min. The PCR products were elec-
trophoresed on 1.5% agarose gel containing ethidium bro-
mide and then photographed under UV light.
Statistical analysis
The significance of differences between groups was evalu-
ated by using chi-square test. Differences were considered
to be statistically significant at p<0.05.
RESULTS
Experimental rats showed abnormally dilated esophagus,
and esophageal inner surface displayed whitish nodular patch-
es, which were prominent in lower esophagus. Superficial
ulcers were present mainly in lower esophagus (Fig. 2). All
these macroscopic findings were present in all rats except
control. 
We evaluated the histologic change in the lower esophagus
of experimental and control rats. Barrett’s esophagus did not
occur in control rats. In contrast, 86% of experimental rats
showed glandular metaplasia including goblet cells above
esophagoduodenal junction. As shown in Table 1, long and
atypical Barrett’s esophagus were restricted to rats exposed to
duodenal contents reflux for 30 and 40 weeks. The glandular
metaplasia was thought to have originated from the lower eso-
phagus because all lesions were above the esophageal anasto-
mosis and had an intact esophageal muscularis propria layer
on histology. 
We have performed immunohistochemical staining in order
to examine the expression and immunolocalization of iNOS.
As shown in Fig. 3, iNOS expression was hardly detectable
in either epithelial or stromal cells of control rats. In contrast,
iNOS immunoreactivity was clearly observed in the epithe-
lial cells of Barrett’s esophagus, predominantly at the apical
surface of epithelial cells. Cytoplasmic staining was also seen
only in atypical Barrett’s esophagus. We compared iNOS
′
′′
′′
′
′
′
*BE, Barrett’s esophagus.
No. No BE* Short BE Long BE BE with atypia
10 week 2 1 1 0 0
20 week 12 2 10 0 0
30 week 8 1 1 3 3
40 week 7 1 3 3
Table 1. Incidence of glandular lesions of esophagoduodenal
junction in experimental rats
Fig. 3. Histology and immunohistochemi-
cal staining of esophagogastric junction
and Barrett’s esophagus. Histology (A-D)
and immunohistochemical staining (E-H,
iNOS) of control esophagogastric junction
(A, E) and Barrett’s esophagus (B-D, F-H).
Esophagogastric junction of control rats did
not show iNOS expression (E). Short (F)
and long (G) Barrett’s esophagus revealed
iNOS expression in apical surface of epithe-
lial cells. Atypical Barrett’s esophagus (H)
revealed immunolocalization of iNOS in the
cytoplasm of epithelial cells. Magnification:
A, E, F ×400; B, C, G ×200; D, H ×100.
A B C D
E F G H
H&E
Normal Short BE Long BE BE with atypia
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expression according to Barrett’s esophagus types. As shown
in Fig. 4, type did not influence iNOS expression (p>0.05). 
To confirm the immunohistochemical staining, we per-
formed RT-PCR. iNOS mRNA was detected in the lower
esophagus of experimental rats and not in that of control rats
(Fig. 5A). To determine which sites express iNOS in experi-
mental rats, RT-PCR analysis was performed in duodenum,
and upper and lower esophagus. iNOS mRNA was expressed
only in lower esophageal portion (Fig. 5B).
DISCUSSION
Eighty six percent (25/29) of rats undergoing esophago-
duodenal anastomosis have developed Barrett’s esophagus,
but definite adenocarcinoma did not occur. This finding may
be explained by the experiment of Chen and Yang (21). They
have reported that iron supplementation promoted the for-
mation of esophageal adenocarcinoma originated from Bar-
rett’s esophagus induced by surgical techniques of esophago-
duodenal or esophagogastroduodenal anastomosis (21).
The present study demonstrates that Barrett’s esophagus
induced by chronic duodenal contents reflux expresses iNOS.
Two previous studies reported that iNOS expression was in-
creased in Barrett’s esophagus-associated neoplastic progres-
sion in human and rat (10, 12). Aberrant iNOS expression
may be one of the phenotypical changes in gene expression
associated with carcinogenesis of esophageal adenocarcinoma.
However, the biological significance of increased iNOS in
gastrointestinal carcinogenesis is difficult to specify. It has
been reported earlier that iNOS is expressed to an apprecia-
ble extent in the epithelium of the normal human colon and
that levels are in fact reduced in colonic neoplasms (22, 23).
A recent study demonstrated that lack of iNOS promoted
intestinal tumorigenesis in the ApcMin/+ mice (24). In con-
trast, Ahn and Ohshima reported that administration of iNOS
inhibitors resulted in significant decrease in adenoma devel-
opment in the small bowel in the ApcMin/+mice, and iNOS
gene knockout ApcMin/+ mice developed fewer adenomas
in both small and large bowels than in wild type mice (25).
Takahashi et al. also found that iNOS expression was increased
in rat colon tumors induced by azoxymethane (11). There-
fore, it may be useful in clarifying the biological role of iNOS
expression on Barrett’s esophagus-associated adenocarcinoma
to study the effect of iNOS inhibitor on animal esophageal
adenocarcinoma model.
We have observed over-expression of COX-2, microsomal
prostaglandin synthase-1 and EP receptors in this model (18).
Recently, PGE2 mediates up-regulation of iNOS in murine
breast cancer cell line through EP4 receptors activation (26).
NO has been also found to enhance the activity and expres-
sion of COX-2 (27, 28). Use of COX-2 inhibitors resulted
in a reduction of the development of esophageal adenocarci-
noma induced by duodenal reflux (29). These findings sug-
gest that cross talk between NO and COX pathway may play
an important role in Barrett’s esophagus-associated neoplas-
tic progression. In Barrett’s esophagus, iNOS expression was
observed at the cytoplasmic area of stromal and epithelial cells
(10, 12). In contrast, our study revealed characteristic local-
ization at the apical surface of epithelial cells. This result is
in agreement with immunolocalization of iNOS in rat colon
tumors induced by azoxymethane (11). Its significance remains
to be determined.
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